Objectives: Cryptococcus neoformans is the most incriminated fungal pathogen causing meningitis in acquired immune deficiency syndrome (AIDS) patients, and is known to constitute a major cause of deaths in AIDS patients. This study thus aimed to determine the baseline sero-prevalence of Cryptococcus neoformans infection in anti-retroviral naïve (ART-naïve) AIDS patients using the serum Cryptococcal antigen (crag) detection method. Baseline effect of variation in CD4 counts, as well as sex and age with seropositivity for crag were also determined. Methods: This descriptive cross-sectional study included 150 (61 males and 89 females) ART-naïve AIDS patients attending the Human Immunodeficiency Virus clinic (HIV) at the University of Benin Teaching hospital, Benin City, Nigeria, within the period from February 2011-July 2011. Forty (18 males and 22 females) HIV positive outpatients with CD4 counts >200 cells/ μl who were ART-naive were recruited and used as controls. The sero-prevalence of crag in the patients and the control group was measured using the cryptococcal antigen latex agglutination system (CALAS) (Meridian Bioscience, Europe) and CD4 counts were measured using flow cytometry (Partec flow cytometer, Germany). Results: Of the 150 ART-naïve AIDS patients with CD4 counts ≤200 cells/μL; 19 (12.7%) were positive for serum Cryptococcal antigen. ART-naïve AIDS patients with CD4 count ≤50 cells/μl had the highest prevalence of serum crag. Lower CD4 counts were significantly associated with positivity for serum crag (p<0.001). Age and sex had no significant effect on the sero-positivity for serum crag. One (2.5%) of the controls was sero-positive for crag. Thus, serum crag was significantly associated with AIDS but not with HIV (p<0.001).
Introduction
Crypt ococcus neoformans is the most incriminated fungal pathogen causing meningitis in patients with acquired immunodeficiency syndrome (AIDS). 1, 2 The type of cryptocococcis encountered in human immunodeficiency virus (HIV) is quite different when it has progressed to AIDS. Meningoencephalithis and cryptococcal pneumonia are the common cryptococcal infections found in HIV and AIDS respectively. 3 Obligatory and effective administration of anti-retroviral agents in AIDS have been proven to reduce the incidence of cryptocococcis. 4 The development of cryptocococcis as with other opportunistic infections during AIDS is associated with a decline in CD4 (Cluster of differentiation) T cell counts in patients. 5 Clinical manifestation of infection with Cryptococcus neoformans in AIDS patients is generally more evident at CD4 cells ≤50 cells/μl. 6 Cryptocococcis in AIDS is usually asymptomatic and its defining illness is commonly not found in the early course of infection. 7 Onset of clinical cryptocococcis in AIDS is found with unspecific clinical symptoms as it is found in most pulmonary and meningeal diseases. Coughing, sweating, fevers, malaise, shortness of breath are common presenting symptoms. The finding of Cryptococcal antigen in the blood represents a condition of systemic invasion with the fungus. 8 At this stage there is the capacity of the fungus to disseminate to major parts of the body. The central nervous system is the commonest site of its dissemination, though cutaneous and adrenal dissemination which are rare are also found in some cases. 9 The clinical course an ART-naïve AIDS patient that may follow will be rightly tracked and planned if diagnosis of cryptococcal antigenemia is done before initiation of ART. This study thus aimed to determine the prevalence of serum Cryptococcal antigenemia in antiretroviral-naïve AIDS patients with varying CD4 counts at the University of Benin teaching hospital, UBTH, Benin City, Nigeria.
Methods
This descriptive cross-sectional study was carried out in the period of February 2011-July 2011 at the HIV clinic of the University of Benin teaching hospital, Benin City, Nigeria-a referral hospital for AIDS patients in Southern Nigeria. It also houses the SouthSouth regional headquarters of the Institute of human virology, Nigeria, and the Action project molecular research laboratory for HIV diagnosis. Ethical approval for the study was granted by the ethical committee of the University of Benin teaching hospital (UBTH), Benin City, Nigeria. A total of 150 anti-retroviral naïve AIDS patients (61 Males and 89 females) within the age groups <20 to >50 who were counseled, consented for the study and were included in this study. They were patients confirmed to have progressively developed AIDS with CD4 T cell count <200 cells/ μl but had not been on anti-retroviral medications in the period of the study. Forty (18 males and 22 females) HIV patients with CD4 counts >200 cells/μl who were ART-naïve were recruited from the special treatment clinic of UBTH and used as controls. History of cryptococcal meningitis, prior positivity for Cryptococcus neoformans and anti-retroviral use were used as exclusion criteria.
Blood samples were collected by veni-puncture and centrifuged to obtain serum. Laboratory analysis of samples was done at the PEPFAR (President' s Emergency Plan for AIDS Relief) laboratory of UBTH, Benin City. Cryptococcal antigen testing was done using cryptococcal antigen latex agglutination system (CALASR) (Meridian Bioscience; Inc, Europe). This detection kit is simple, sensitive, qualitative and semi -quantitative latex test which detects capsular polysaccharide antigens of Cryptococcus neoformans in Serum and cerebrospinal fluid. Samples were initially pre-treated by incubation at 50°C for 15 mins with CALAS (R) pronase (Meridian Bioscience; Inc, Europe) to reduce non-specific interference with cryptococcal antigen latex test. All tests were carried out according to the manufacturer' s instructions. Determination of CD4 T cell counts in the patients was done using flow cytometry (Partec flow cytometer, Germany). In brief, equal volumes (20 μl) of CD4 PE antibody and Ethylene diamine tetra acetic acid blood was mixed and incubated for 15 mins, and 800 μl of CD4 buffer was added before reading in the cell counter.
Data was analyzed for significance using the chi-square test with Statistical packages for social sciences (SPSS) V. 15 and p<0.05 was taken as significant.
Results
One hundred and fifty patients with immunologic AIDS (CD4 cell count <200 cells/μl) who were not on anti-retroviral therapy were studied. Nineteen (12.7%) were positive for cryptococcal antigen. Prevalence of Cryptococcal antigen was quite varied with CD4 cells levels; CD4 count ≤50 cells/μl had a higher prevalence of cryptococcal antigen (Table 1 ). This was followed by CD4 cell counts >50-≤100 cells/μl and >100-≤200 cells/μl. Lower CD4 counts were significantly associated with positivity for serum cryptococcal antigen (p<0.001). One (2.5%) of the control was sero-positive for crag. Serum crag was significantly associated with AIDS but not with HIV (p<0.001). Sex was not associated with crag positivity. Also, higher cryptococcal antigenemia were recorded among the age group 31-40 when compared to other age groups (Table 2) . However, age and sex had no effect on seropositivity for crag. 
Discussion
This study demonstrates a high prevalence of serum cryptococcal antigen in ART-naïve AIDS patients in Benin City, Nigeria. Nineteen (12.7%) of the studied patients were positive for serum cryptococcal antigen. The finding of this study concurs with the 12.2% in Congo, 12.9% in Bangkok and 13.5% in Kampala, Uganda. [10] [11] [12] The prevalence report of this study is relatively higher than the prevalence rates of other countries; 7% was reported in a retrospective study on ART-naïve AIDS patients in South Africa, 13 and 9.2% in Thailand. 14 Higher prevalence of cryptococcal antigenemia has been reported in Cambodia (21%). 15 The high rate recorded in these patients represents the burden of cryptococcal infection in AIDS patients in Benin City. An earlier study evaluating the prevalence of fungal opportunistic infections in AIDS patients largely on ART-therapy in a hospital using culture and microscopy recovered a 9.7% prevalence of Cryptococcus neoformans. 16 The study further goes to confirm the burden of cryptocococcis in AIDS patients at that hospital. Thus, screening for cryptocococcis in AIDS patients should be made a routine.
The distribution of cryptococcal antigenemia was highly varying with CD4 cell levels. Patients with CD4 cell count ≤50 cell/μl had the highest prevalence of serum crag; this was closely followed with patients with CD4 cells >50-≤100 cell/μl and >100-≤200 cells/ μl. Several studies evaluating the prevalence of serum cryptococcal antigenemia in AIDS patients have reported a consistently higher prevalence of serum crag in patients with lower CD4 cell counts. 17, 18 HIV is characteristically associated with T lymphocyte depletion and is highly marked in ART-naïve patients. 13, 19 Females had more seropositivity for crag when compared to their male counterparts. More men compared to women have been reported to carry a higher burden in the United States, 20 but there were no significant difference in the prevalence in men and women in ART-naïve AIDS patients in Benin City. Age also did not play a significant role in serum crag positivity in the patients.
The present study was aimed to determine the baseline serum cryptococcal antigen prevalence in ART-naïve AIDS patients in Benin City, Nigeria. A one year follow-up evaluation of the prevalence of serum crag, mortality and morbidity ratio in ARTnaïve AIDS patients who were seropositive or sero-negative for crag in the preliminary survey is being studied and will be reported later. The key to reducing the mortality from Cryptococcal meningitis, which is a consequent of crag positivity, is early diagnosis of crag in ART-naïve AIDS patients prior to initiation of ART therapy and the integration of both ART therapy and primary prophylaxis with Fluconazole; this has been shown to reduce mortality from Cryptococcal meningitis consequent of crag positivity even at CD4 cell count within the range of ≤100 cells/ μl to 25 cells/μl.
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Conclusion
Overall, 12.7% ART-naïve AIDS patients at UBTH, Benin City, were crag positive. Crag prevalence was significantly associated with lower CD4 counts. ART-naïve AIDS patients with CD4 counts ≤50 cells/μl had the highest prevalence. The sero-prevalence of crag was high; thus screening for Cryptococcus neoformans antigen should be made a routine in ART-naïve AIDS patients before initiation of ART therapy to reduce the rapid mortality from Cryptococcal meningitis.
